Physician profile
Troy Skidmore
NPI 1104870997
$13,244.83
in general payments reported to CMS, 2019-2025
15 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $1,261 · 2021: $4,953 · 2022: $1,655 · 2023: $3,233 · 2024: $1,459 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,118 · Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,118.38 |
| Food and Beverage | $1,082.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $7,983.76 | 2020-2025 | |
| Arthrex, INC. | $3,224.10 | 2021-2023 | |
| Zimmer Biomet Holdings, INC. | $1,472.91 | 2019-2025 | Avenir, Persona |
| Stryker Corporation | $205.25 | 2021-2025 | Mako, Aequalis Perform+, Tornier Perform Reversed Glenoid |
| Ferring Pharmaceuticals INC. | $129.14 | 2019-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $50.51 | 2019 | |
| Sanara Medtech INC. | $42.37 | 2024 | Celleraterx |
| Depuy Synthes Sales INC. | $26.49 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.15 | 2024 | Zilretta, Exparel |
| Vertex Pharmaceuticals Incorporated | $20.10 | 2025 | |
| Kinex Medical Company LLC | $14.91 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $14.69 | 2019 | |
| Bioventus LLC | $13.52 | 2023 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $12.75 | 2019 | |
| Djo, LLC | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Skidmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.